Block by fluoxetine of volume-regulated anion channels

被引:65
作者
Maertens, C [1 ]
Wei, L [1 ]
Voets, T [1 ]
Droogmans, G [1 ]
Nilius, B [1 ]
机构
[1] Katholieke Univ Leuven, Fysiol Lab, B-3000 Leuven, Belgium
关键词
patch-clamp; volume-regulated anion channels; fluoxetine; Ca2+-activated Cl- currents; cystic fibrosis transmembrane conductance regulator; endothelium;
D O I
10.1038/sj.bjp.0702314
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have used the whole-cell patch clamp technique to study the effect of fluoxetine, a commonly used antidepressant drug, on the volume-regulated anion channel (VRAC) in calf pulmonary artery endothelial (CPAE) cells. We also examined its effects on other Cl- channels, i.e. the Ca2+-activated Cl- current (I-Cl . Ca,) and the cystic fibrosis transmembrane conductance regulator (CFTR) to assess the specificity of this compound for VRAC. 2 At pH 7.4 fluoxetine induced a East and reversible block of the volume-sensitive chloride current (I-Cl.swell), with a K-i value of 6.0 +/- 0.5 mu M (n = 6-9]. The blocking efficiency increased with increasing extracellular pH (K-i = 0.32 +/- 0.01 mu M at pH 8.8, n = 3-9), indicating that the blockade is mediated by the uncharged form of fluoxetine. 3 Fluoxetine inhibited Ca2+-activated Cl- currents, I-Cl . Ca activated by loading CPAE cells via the patch pipette with 1000 nM free Ca2+ (K-i = 10.7 +/- 1.6 mu M at pH 7.4, n = 3-5). The CFTR channel, transiently transfected in CPAE cells, was also inhibited with a K-i value of 26.9 +/- 9.4 mu M at pH 7.4 (n = 3). 4 This study describes for the first time the effects of fluoxetine on anion channels. Our data reveal a potent block of VRAC at fluoxetine concentrations close to plasma concentrations. The results suggest a hydrophobic interaction with high affinity between uncharged fluoxetine and volume-activated chloride channels. Ca2+-activated Cl- currents and CFTR are also blocked by fluoxetine, revealing a novel characteristic of the drug as a chloride channel modulator.
引用
收藏
页码:508 / 514
页数:7
相关论文
共 37 条
[1]   CLINICAL PHARMACOKINETICS OF FLUOXETINE [J].
ALTAMURA, AC ;
MORO, AR ;
PERCUDANI, M .
CLINICAL PHARMACOKINETICS, 1994, 26 (03) :201-214
[2]   Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors [J].
Baumann, P .
CLINICAL PHARMACOKINETICS, 1996, 31 (06) :444-469
[3]  
Bausch AR, 1996, GLIA, V18, P73, DOI 10.1002/(SICI)1098-1136(199609)18:1<73::AID-GLIA8>3.0.CO
[4]  
2-4
[5]   CAMP-ACTIVATED CL CHANNELS IN CFTR-TRANSFECTED CYSTIC-FIBROSIS PANCREATIC EPITHELIAL-CELLS [J].
CLIFF, WH ;
SCHOUMACHER, RA ;
FRIZZELL, RA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :C1154-C1160
[6]   Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes - The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation [J].
Cuppens, H ;
Lin, W ;
Jaspers, M ;
Costes, B ;
Teng, H ;
Vankeerberghen, A ;
Jorissen, M ;
Droogmans, G ;
Reynaert, I ;
Goossens, M ;
Nilius, B ;
Cassiman, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :487-496
[7]   Modulation of ionic currents in isolated canine and human jejunal circular smooth muscle cells by fluoxetine [J].
Farrugia, G .
GASTROENTEROLOGY, 1996, 110 (05) :1438-1445
[8]   INHIBITION OF VOLUME-ACTIVATED CHLORIDE CURRENTS IN ENDOTHELIAL-CELLS BY CHROMONES [J].
HEINKE, S ;
SZUCS, G ;
NORRIS, A ;
DROOGMAND, G ;
NILIUS, B .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (08) :1393-1398
[9]   STRUCTURAL MODEL OF ATP-BINDING PROTEINS ASSOCIATED WITH CYSTIC-FIBROSIS, MULTIDRUG RESISTANCE AND BACTERIAL TRANSPORT [J].
HYDE, SC ;
EMSLEY, P ;
HARTSHORN, MJ ;
MIMMACK, MM ;
GILEADI, U ;
PEARCE, SR ;
GALLAGHER, MP ;
GILL, DR ;
HUBBARD, RE ;
HIGGINS, CF .
NATURE, 1990, 346 (6282) :362-365
[10]   Modulation of inwardly rectifying potassium channels in cultured bovine pulmonary artery endothelial cells [J].
Kamouchi, M ;
VandenBremt, K ;
Eggermont, J ;
Droogmans, G ;
Nilius, B .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 504 (03) :545-556